Bone Marrow Transplant Stocks List
Related Industries: Medical Care
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
AZTD | D | Aztlan Global Stock Selection DM SMID ETF | 4.21 | |
PTH | D | Invesco DWA Healthcare Momentum ETF | 3.04 | |
DVLU | C | First Trust Dorsey Wright Momentum & Value ETF | 2.99 | |
GVIP | B | Goldman Sachs Hedge Industry VIP ETF | 2.35 | |
QMOM | C | MomentumShares U.S. Quantitative Momentum ETF | 2.01 |
Compare ETFs
- Bone Marrow Transplant
Hematopoietic stem-cell transplantation (HSCT) is the transplantation of multipotent hematopoietic stem cells, usually derived from bone marrow, peripheral blood, or umbilical cord blood. It may be autologous (the patient's own stem cells are used), allogeneic (the stem cells come from a donor) or syngeneic (from an identical twin).It is most often performed for patients with certain cancers of the blood or bone marrow, such as multiple myeloma or leukemia. In these cases, the recipient's immune system is usually destroyed with radiation or chemotherapy before the transplantation. Infection and graft-versus-host disease are major complications of allogeneic HSCT.HSCT remains a dangerous procedure with many possible complications; it is reserved for patients with life-threatening diseases. As survival following the procedure has increased, its use has expanded beyond cancer to autoimmune diseases and hereditary skeletal dysplasias; notably malignant infantile osteopetrosis and mucopolysaccharidosis.
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles